Navinci

Navinci is a Swedish biotechnology company based in Uppsala, specializing in innovative solutions for studying protein interactions, expression, and post-translational modifications.

Founded in 2004 by Ulf Landegren and colleagues at Uppsala University, Navinci has established itself as a leader in spatial proteomics and spatial biology. The company’s core technology is the Naveni® in situ proximity ligation assay (PLA), which allows for the precise detection and quantification of proteins directly within biological samples. Navinci offers a range of research-focused services, including spatial proteomics research solutions, in situ protein detection, and post-translational modification analysis. They also collaborate with academic and pharmaceutical partners for custom research support and are developing clinical-grade diagnostic tools through Navinci Diagnostics AB. Navinci primarily serves the research community and the biopharmaceutical industry, providing essential tools for academic research groups, pharmaceutical companies, and clinical researchers. With a strong commitment to advancing the field of spatial biology, Navinci is well-positioned for future growth and innovation in drug development and precision medicine.